8-K: American Well Director Resigns for New Role
Departure of Directors or Certain Officers
Dr. Peter Slavin is resigning from the American Well Corporation Board of Directors effective at the company's 2026 annual meeting, citing a move to the West Coast.
Summary
- Dr. Peter Slavin has informed American Well Corporation of his decision to resign from the Board of Directors.
- His resignation will be effective at the company's next annual stockholders meeting in 2026.
- Dr. Slavin will continue to serve as a director until that meeting.
- The reason for his resignation is a transition to a new role on the West Coast.
- This decision is not due to any disagreements with the Company regarding its operations, policies, or procedures.
- The Company expressed gratitude for Dr. Slavin's over nine years of service on the Board.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the resignation is amicable and the director will serve until the next annual meeting, minimizing immediate disruption.
Positives
- Dr. Slavin's departure is amicable and not due to any disagreements with the company.
- Dr. Slavin will continue to serve until the next annual meeting, ensuring a smooth transition.
- The company acknowledges and thanks Dr. Slavin for his significant tenure of over nine years.
Negatives
- The company is losing a director with over nine years of experience.
Risks
- Potential for a brief period of adjustment on the Board as a new director may be sought.
- Loss of institutional knowledge held by a director with extensive tenure.
Future Outlook
No specific future outlook or guidance is provided in this filing.
Management Comments
- The Company thanks Dr. Slavin for his more than nine years of service as a member of the Companys Board of Directors.
Industry Context
StockSavvy.ai notes that director resignations, especially those not tied to disagreements, are common as executives pursue new opportunities or relocate. The key for American Well will be ensuring continuity and potentially identifying a successor with relevant expertise to maintain Board effectiveness.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Dr. Peter Slavin | 2026 (at the annual meeting) | Transition to a new role on the West Coast of the United States. |
Stakeholder Impact
- Shareholders: Minimal immediate impact, as the resignation is amicable and effective at a future date. Long-term impact depends on the replacement director's qualifications.
- Board of Directors: May require a period of adjustment and a search for a new member to maintain optimal board composition and expertise.
- Management: No direct impact indicated, as the resignation is not due to disagreements.
Next Steps
- Dr. Peter Slavin will continue to serve as a director until the company's next annual meeting of stockholders in 2026.
- The company will likely identify and appoint a new director to fill the vacancy.
Key Dates
| Date | Description |
|---|---|
| 2026-04-01 | Date of earliest event reported (Dr. Peter Slavin notified American Well Corporation of his resignation). |
| 2026 | Year of the Company's next annual meeting of stockholders, at which time Dr. Slavin's resignation will be effective. |
Keywords
American Well Corporation, Board of Directors, Director Resignation, Corporate Governance, Stockholder Meeting, Executive Transition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.